3,Most Critical Antimicrobial-Resistant Bacteria

Hospital-Acquired Bacteria of Greatest Concern in Japan

1. MRSA (Methicillin-Resistant Staphylococcus aureus)

• Representative causative pathogen of hospital-acquired infections in Japan

• According to JANIS data, approximately 50-60% of Staphylococcus aureus isolates are MRSA

• Particularly serious problem in elderly care facilities

2. Multidrug-Resistant Pseudomonas aeruginosa (MDRP)

・Problematic infections in intensive care units　　　・Cause of severe infections with high mortality rates

3. Carbapenem-Resistant Enterobacteriaceae (CRE)

・Increasing trend in recent years　　　　　　　 　・Extremely limited therapeutic options

Hospital-Acquired Bacteria of Greatest Concern in the United States

CDC "Urgent Threats" (Highest Alert Level)

1. Clostridioides difficile (C. diff)

・Approximately 29,000 deaths annually　　　　　　　・Primary cause of antibiotic-associated diarrhea

2. Carbapenem-Resistant Enterobacteriaceae (CRE)

・Approximately 1,100 deaths annually　　　　　　　 ・High fatality rate with about 50% of infected patients dying

3. Drug-Resistant Gonorrhea

• Primarily sexually transmitted, but hospital-acquired mother-to-child transmission is also a concern

CDC "Serious Threats"

・MRSA: Approximately 10,600 deaths annually (significant decrease from peak levels)

・Multidrug-Resistant Acinetobacter　　　　　　　　・Multidrug-Resistant Pseudomonas aeruginosa

Numerical Data

United States (CDC Data)

• Annual deaths from hospital-acquired infections: approximately 75,000 people

• Annual increase in healthcare costs: approximately $20-35 billion

• Average hospital stay extension due to MRSA infection: 7-10 days

Japan

• While JANIS data provides detailed resistance rates, accurate statistics on deaths are limited

• Estimated economic loss due to antimicrobial-resistant bacteria: approximately 800 billion yen annually

Important Trends

• In the United States, MRSA has been declining in recent years, with C. diff and CRE being the most critical issues

• In Japan, MRSA remains a major problem, with increasing concern about CRE​

Comparison of Policies and Countermeasures

US National Strategy

National Action Plan (2020-2025):

・Establishment of CARB (Combating Antibiotic Resistant Bacteria)　　・Annual budget allocation of $1.2 billion

・One Health approach　　　　　　　　　　　　　　　　　　　　　 ・CDC-led surveillance enhancement

Major Programs:

・Mandatory Antibiotic Stewardship Programs　　　　　・NHSN (National Healthcare Safety Network)

・Establishment of CDC's AR Lab Network　　　　　・Promotion of IDSA/SHEA guideline compliance

Japan's National Strategy

AMR Action Plan (2023-2027):

・Cross-ministerial framework led by the Cabinet Secretariat　　・Annual budget of approximately 5 billion yen

• J-SIPHE (Japan Surveillance for Infection Prevention and Healthcare Epidemiology)

• Expansion of JANIS (Japan Nosocomial Infections Surveillance)

Major Initiatives:

・Infection Control Specialist Pharmacist System

・Establishment of antimicrobial stewardship support reimbursement

・AMR Clinical Reference Center establishment　・Construction of evaluation system within medical fee schedule​​

​４、Why Are Infectious Diseases Considered an Eternal Challenge for

　　　　Humanity?

１、Biological Characteristics of Pathogens 

• High adaptability: Pathogens rapidly adapt and evolve in response to environmental changes

• Speed of mutation: Particularly viruses generate new strains through genetic mutations

• Acquisition of drug resistance: Pathogens acquire resistance to antibiotics and other treatments, making therapy difficult

２、Characteristics of Infection Spread 

• Exponential growth: Rapid spread from one person to multiple individuals

• Asymptomatic carriers: Infection can spread even without symptoms

• Globalization: Human and goods movement enables worldwide spread within short periods

３、Limitations of Prevention and Treatment 

• Difficulty of complete prevention: No preventive measures exist with 100% efficacy

• Emerging infectious diseases: New threats from unknown pathogens appear periodically

• Vaccine development time: Developing vaccines against new infectious diseases requires significant time

４、Socioeconomic Factors 

• Sanitation disparities: Differences in sanitary conditions across regions and social strata​​​

5、　The U.S. EPA approved copper alloys as continuous antimicrobial agents

　　　in 2008.

1. Innovation of the Copper Alloy Approach 

Significance of EPA Approval

• 2008 EPA Approval: First-ever certification of continuous antimicrobial activity for solid surface materials

• Contact Disinfection: Physical contact-based disinfection rather than pharmaceutical administration

• MRSA, VRE, etc.: Clinical demonstration of effectiveness against multidrug-resistant bacteria

2. Important Insights from This Approach 

Resistance Avoidance Mechanism

• Conventional: Biological targets → resistance acquisition possibl

• Copper Alloys: Physicochemical destruction → resistance acquisition difficult

Multi-target Simultaneous Attack

• Cell membrane destruction • Enzyme function inhibition • DNA damage • Respiratory chain inhibition ​　　　　　　　　　　　　　　　　Since these occur simultaneously, resistance acquisition is extremely difficult

3. New Paradigm Demonstrated by the Copper Alloy Approach 

Shift from "Pharmaceuticals" to "Environment"

• Old Paradigm: Post-infection pharmaceutical treatment

• New Paradigm: Creating environments that prevent infection

Fundamental Solution to Antibiotic Resistance Problems

• Avoidance of Evolutionary Pressure: Physical attacks to which bacteria cannot adapt

• Prevention Priority: Strategic shift from treatment to prevention

• Sustainability: Solutions with long-lasting effectiveness

4. Future Challenges

• Biocompatibility optimization • Avoidance of local toxicity • Selective disinfection (protection of resident flora) • Cost and versatility​​

6、 Reasons for Using Silver Ions Generated by Electrolysis as Active 

     Species.

1. Fundamental Advantages of Silver Ions

Safety Already Established through FDA and EPA Approval

Long-term evaluation by regulatory authorities:

• FDA approval: Authorized for use in medical devices and food contact materials

• EPA approval: Officially certified for environmental safety and antimicrobial efficacy

• Decades of usage history: No reports of serious adverse effects

• International standards compliance: Safety confirmed by WHO, EU, and other organizations

Comparison with other antimicrobial components: → Novel compounds: Require 10-15 years for safety evaluation → Organic antimicrobial agents: Concerns about carcinogenicity and mutagenicity → Silver ions: Safety already established

Broad-spectrum Antimicrobial Activity

Wide range of target microorganisms:

• Gram-positive bacteria: Including resistant strains such as MRSA and VRE

• Gram-negative bacteria: E. coli, Pseudomonas aeruginosa, carbapenem-resistant bacteria

• Fungi: Candida, Aspergillus, etc.

• Viruses: Both enveloped and non-enveloped types

• Spores: Spore-forming bacteria such as Clostridium

Comparison with other agents: → Organic antimicrobial agents: Limited to specific bacterial species → Photocatalysts: Effective only under light irradiation conditions → Silver ions: Broad-spectrum efficacy regardless of environmental conditions​​

7、 Challenges of Conventional Silver-based Antimicrobial Agents and New 

      Proposals 

Fundamental Challenges of Conventional Technology

Effect Attenuation Due to Water Solubility: • Rapid elution and loss of silver ions • Transient effect: Disappears within hours to days • Easy removal by washing and wiping • No sustained effect: Frequent reprocessing required

Limitations of Conventional Methods: → Duration: Maximum of 50 wash cycles → Effect maintenance: Gradual decline → Practicality: Frequent reprocessing necessary → Cost: High running costs

Resolution Through Technological Breakthrough

Achievement of Controlled Sustained Release: • Strong chemical bonding with substrate material • Silver ion release only when needed • Stepwise and controlled elution mechanism • Maintains 99.9% antimicrobial efficacy even after 300 wash cycles

Innovative Mechanism: → Establishment of reservoir-type silver ion source → Demand-responsive release system → Regeneration and replenishment function → Achievement of long-term stability​​

8、 Advantages of the silver ion disinfection mechanism

Reliability Through Multiple Modes of Action

Effects on cell membrane: • Enhanced cell membrane permeability • Disruption of membrane potential • Leakage of intracellular contents

Intracellular effects: • Inhibition of DNA synthesis • Inhibition of protein synthesis • Inhibition of respiratory enzyme systems • Cessation of cell division

Multiple inhibitory effects: → Resistance acquisition extremely difficult → Rapid antimicrobial efficacy → Reliable cell death induction → Prevention of regrowth of surviving bacteria

Difficulty in Resistance Acquisition

Problems with conventional antimicrobials: • Single target: Easy resistance mutation • Specific pathway inhibition: Avoidable through alternative pathways • Selection pressure: Dominance of resistant strains

Advantages of silver ions: • Simultaneous multi-target attack: Difficult resistance acquisition • Inhibition of basic cellular functions: Unavoidable • Physicochemical action: Genetic resistance impossible

Scientific evidence: → No reports of resistant bacteria despite thousands of years of use → Effective against multidrug-resistant bacteria → Demonstrates efficacy even within biofilms​​

9. Advantages of Silver Ion Disinfection in the Medical Field

Value in Hospital Infection Control

Effectiveness against major pathogens: • MRSA: MIC 0.5–2.0 μg/mL  • VRE: MIC 1.0–4.0 μg/mL  • ESBL-producing bacteria: MIC 0.5–2.0 μg/mL  • Carbapenem-resistant bacteria: MIC 1.0–4.0 μg/mL  • Clostridium: Effective even against spores

Clinical benefits:  → Significant reduction in infection rates: 70–90% reduction  → Shortened treatment duration: average reduction of 3–5 days  → Reduction in medical costs: $5,000–15,000 per patient  → Decreased mortality rate: 20–40% improvement

Applications in Medical Devices and Environments

Wide range of applications:  • Medical instruments: catheters, endoscopes, etc.  • Medical equipment: operating tables, examination tables, etc.  • Hospital room environments: beds, curtains, uniforms  • HVAC systems: filters, ducts

Value of continuous effectiveness:  → Infection control 24 hours a day, 365 days a year  → Reduction of manual workload 

→ Significant decrease in disinfection frequency  → Reliable reduction of infection risk​​

10. Absolute Advantages of Silver Ion Disinfection in Terms of Safety

Accumulated Long-Term Safety Data

Historical record of use:  • Used for antimicrobial purposes since ancient times  • Modern medicine: more than 50 years of clinical use  • Ophthalmology: used as eye drops for newborns  • Wound treatment: used in direct contact with tissues

Safety evaluation data:  → Acute toxicity: extremely low  → Chronic toxicity: no issues with long-term use  → Mutagenicity: negative
→ Carcinogenicity: not observed  → Reproductive toxicity: no adverse effects

Superior Biocompatibility

Tissue compatibility:  • Skin irritation: minimal  • Allergic reactions: extremely rare  • Cytotoxicity: non-toxic at therapeutic concentrations  • Tissue accumulation: metabolized and excreted

Comparison with other agents:  → Organic antimicrobial agents: allergy and sensitization risks  → Heavy metal agents: concerns about cumulative toxicity  → Halogen-based agents: irritant and corrosive  → Silver-based agents: highest level of safety​​

11. Environmental Safety Advantages of Silver Ion Sterilization 

Silver has long been recognized as a highly safe antimicrobial element and has historically been used for water preservation and medical applications. In particular, silver ions (Ag⁺) exhibit strong antimicrobial activity by interacting with bacterial cell membranes and enzymes, thereby inhibiting microbial growth. This antimicrobial effect is effective against a broad range of bacteria and is characterized by a low likelihood of inducing resistant strains.

In recent years, technologies utilizing silver nanoparticles (Ag nanoparticles) as antimicrobial materials have become widespread. However, concerns have been raised regarding the environmental release of these particles and their potential impact on ecosystems. Nanoparticles may persist in the environment for long periods, and their effects on aquatic organisms and ecological systems have been increasingly discussed. While such materials are not currently regulated in Japan, their use has been restricted in parts of Europe and North America due to the lack of comprehensive risk assessments.

In contrast, the antimicrobial system employed in the present technology adopts a method in which electrolytically generated silver ions are stably immobilized on the surface of titanium dioxide microparticles. In this approach, metallic silver nanoparticles are not formed; instead, silver in its ionic state is stabilized through interfacial chemical interactions with the TiO₂ surface.

As a result, the following environmental safety advantages can be obtained.

1. Safety design without nanoparticles
Since this technology does not form silver nanoparticles, the risks associated with nanoparticle dispersion in the environment and potential bioaccumulation can be significantly reduced.

2. Extremely low silver elution
Silver ions are strongly anchored to the TiO₂ surface, and therefore do not significantly leach out even under washing or practical use conditions. This greatly suppresses the release of silver into the environment.

3. Long-lasting antimicrobial functionality
Because the silver ions are stabilized on the material surface, the antimicrobial functionality can be maintained over a long period. This differs from conventional systems that rely on the release of silver ions for antimicrobial activity; instead, it represents a non-leaching antimicrobial system that functions directly at the material surface.

4. Reduction of environmental burden
Since the antimicrobial effect can be maintained for extended periods, frequent reapplication or replacement of antimicrobial agents is unnecessary. This contributes to reductions in resource consumption and waste generation.

In this way, antimicrobial technology based on surface-stabilized silver ions is expected to serve as a sustainable antimicrobial material that combines high antimicrobial performance with environmental safety. It has potential applications in a wide range of fields, particularly in textile products, medical-related materials, and high-contact surfaces in public spaces, where both safety and durability are required.​

12. Economic Advantages of Silver Ion Antimicrobial Technology

1. High Antimicrobial Efficacy at Extremely Low Concentrations (Reduced Material Cost)

Silver is well known to exhibit strong antimicrobial activity even at extremely low concentrations due to the oligodynamic effect. In other words, a very small amount of silver ions (Ag⁺) can effectively suppress the growth of a wide range of microorganisms.

Typical target microorganisms include:・Escherichia coli　　・Staphylococcus aureus　　・Fungi　　・Various other bacteria and molds

Because of this characteristic, silver ions can achieve sufficient antimicrobial performance at ppm-level concentrations.

Economic advantages:・Only ppm-level addition is required　　・Material costs can be significantly reduced　　・Effective simultaneously against a broad spectrum of microorganisms

Therefore, silver is considered one of the most cost-efficient antimicrobial materials due to its low dosage and broad antimicrobial spectrum.

Initial cost：

• Silver raw material: relatively expensive, but required in extremely small quantities

• Processing cost: compatible with existing coating and material processing equipment

• Quality control: well-established analytical methods such as ICP and XPS are available

Running cost

Because silver antimicrobial materials exhibit long-term durability, operational costs can be significantly reduced.

• Reprocessing frequency: reduced to approximately 1/10–1/30 of conventional disinfection

• Labor costs: significantly reduced

• Consumable costs: minimized

Total Cost of Ownership (TCO)→ Expected reduction of approximately 50–80%

2. Long-Term Antimicrobial Activity (Reduction of Reprocessing Costs)

Conventional chemical disinfectants such as:・Alcohol　　・Sodium hypochlorite　　・Quaternary ammonium compounds

lose their antimicrobial effectiveness soon after drying.

In contrast, silver-based antimicrobial materials exhibit the following characteristics:

• Surface-immobilized Ag⁺ ions continuously exert antimicrobial activity

• Coating materials may maintain antimicrobial functionality for years

Long-term economic benefits：・Reduction of infection control costs　　・Improved operational efficiency and productivity　　・Enhanced product quality　　・Increased brand value

Investment efficiency (example)：・ROI (Return on Investment): 300–500% per year　　・Payback period: 6–12 months　　・NPV (Net Present Value): high

Such long-term durability also contributes to the establishment of competitive advantages for companies and facilities.

3. Reduction of Maintenance Costs

Once incorporated into materials, silver antimicrobial systems generally require minimal maintenance such as:・Rewashing　

・Recoating　　・Re-disinfection

Typical applications include:・Antimicrobial textiles　　・Medical devices　　・Air filtration systems　　・Water treatment materials

In these fields, significant reductions in operational costs have been reported.

Silver antimicrobial technology can be applied across many industrial sectors.

Major application areas include:・Medical devices　　・Water treatment　　・Air purification　　・Antimicrobial textiles　　・Food packaging

・Construction materials

Because the same technology platform can be deployed across multiple industries, the efficiency of research and development cost recovery is significantly improved.

5. Summary: Economic Value of Silver Ion Antimicrobial Systems

In materials science, the advantages of silver antimicrobial materials are often summarized as:　“Low dose – Long durability – Wide spectrum antimicrobial.”　In other words, the combination of low dosage, long-lasting effectiveness, and broad antimicrobial activity is the key factor that provides the excellent cost performance of silver ion–based antimicrobial technologies.

​

​

​​​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

13. Technical Advantages of the Electrolytic Silver Ion Long-Lasting 

      Antimicrobial  Agent “AbedulAg⁺”

Conventional chemically synthesized antimicrobial agents generally exhibit only transient efficacy, as their active components are rapidly consumed, degraded, or deactivated during use. Consequently, their long-term performance is limited, particularly under repeated washing or prolonged environmental exposure. In parallel, numerous long-lasting antimicrobial systems based on nano-silver particles have been developed; however, these systems have raised increasing concerns regarding cytotoxicity, environmental persistence, and regulatory compliance. Indeed, the use of nano-silver is subject to regulation or scrutiny in certain regions, including parts of Europe and North America, due to the potential risks associated with nanoparticle release and accumulation.

Against this background, the electrolytically generated silver ion–based antimicrobial system “AbedulAg⁺” represents a significant technological advancement. Unlike conventional nanoparticle-based approaches, this system employs electrochemically generated silver ions (Ag⁺) as the active antimicrobial species, which are stabilized within an inorganic or ceramic matrix through interfacial coordination and electrochemical interactions. This design enables a non-particulate, non-leaching antimicrobial mechanism, thereby eliminating the risks associated with nanoparticle detachment and uncontrolled release.

As a result, AbedulAg⁺ achieves sustained antimicrobial performance while maintaining a favorable safety profile and reduced environmental impact. The absence of particulate silver further enhances its compatibility with evolving regulatory frameworks, positioning it as a viable alternative to conventional nano-silver–based technologies. Furthermore, the stability of surface-confined Ag⁺ species ensures prolonged antimicrobial efficacy even under repeated washing and mechanical stress, making the system particularly suitable for applications in textiles and high-contact surfaces.

From a technological perspective, there remains substantial potential for further development. Key areas for improvement include precise control of domain or interfacial structures, optimization of ion release kinetics, and integration with additional functionalities such as antiviral activity, deodorization, and self-cleaning properties. In addition, coupling with AI-based monitoring and control systems may enable real-time optimization of antimicrobial performance under practical usage conditions.

From a strategic standpoint, the establishment of a robust patent portfolio is essential for securing long-term competitiveness. This includes the protection of core technologies, expansion of application-specific intellectual property, and the development of an international patent network, all of which contribute to maintaining strong technological barriers to entry.

Furthermore, AbedulAg⁺ demonstrates strong potential in terms of standardization and market leadership. Its design concept is well aligned with international standardization efforts, including potential adoption within ISO and JIS frameworks, as well as the development of industry guidelines. Compliance with regulatory requirements across multiple regions further enhances its global applicability. Collectively, these factors support the establishment of a de facto standard, enable licensing opportunities, facilitate sustained expansion of market share, and create barriers to the entry of competing technologies.​

14. Why Have EPA-Approved Copper Alloys Not Achieved Widespread

      Implementation? — “AbedulAg⁺”

From Antimicrobial Agents to Antimicrobial Interfaces:

Lessons from Copper Alloys and the Path Forward

The registration of antimicrobial copper alloys by the U.S. Environmental Protection Agency (EPA) in 2008 marked a significant turning point in the history of infection control. For the first time, a solid material was granted public health claims based on continuous antimicrobial activity, establishing the concept of “passive, contact-dependent killing” in real-world environments. Copper alloys demonstrated more than 99.9% reduction of clinically relevant pathogens, including MRSA, within a few hours. Furthermore, clinical trials indicated that healthcare-associated infection (HAI) rates in intensive care units could be reduced by up to approximately 58%. These findings established a new paradigm, showing that infection control can be embedded directly into material surfaces rather than relying solely on intermittent chemical disinfection or pharmacological interventions.

First-Generation Continuous Antimicrobial Materials: Copper Alloys

The effectiveness of copper alloys arises from a multi-modal physicochemical mechanism, including membrane disruption, protein dysfunction, induction of oxidative stress, and DNA damage. Unlike conventional antibiotics that target specific biochemical pathways, this multi-target action significantly reduces the likelihood of microbial resistance development.

Equally important is that copper surfaces function as passive antimicrobial systems independent of human intervention. This characteristic complements the limitations of conventional infection control measures, which rely heavily on compliance with hand hygiene and surface disinfection. In this sense, copper alloys can be regarded as the first practical implementation of “environmental infection control engineering.”

The Translational Gap: Why Has Copper Not Become a Universal Solution?

Despite strong evidence of efficacy in both laboratory and clinical settings, the widespread adoption of copper alloys remains limited. This discrepancy highlights a critical reality: demonstrating antimicrobial performance alone does not guarantee successful implementation. Copper-based approaches face several intrinsic and systemic limitations:

(1) Dependence on Ion Release

The antimicrobial activity of copper inherently depends on the release of Cu⁺/Cu²⁺ ions. While this contributes to its bactericidal effect, it also introduces several issues:

• Decline in activity due to surface degradation (finite durability)

• Concerns regarding environmental and biological toxicity

• Difficulty in precisely controlling local ion concentrations

Thus, copper can be characterized as a thermodynamically and kinetically constrained “leaching-based antimicrobial system.”

(2) Limitations in Killing Kinetics

Although copper exhibits strong antimicrobial effects over extended contact times, it does not necessarily achieve instantaneous sterilization. In clinical settings, microbial transmission can occur more rapidly than copper-mediated inactivation, limiting its effectiveness as a standalone solution.

(3) Environmental Dependence

Organic matter such as proteins and bodily fluids significantly reduces the antimicrobial activity of copper. This leads to discrepancies between laboratory performance and real-world effectiveness, resulting in variability in clinical outcomes.

(4) Lack of Functional Controllability

Copper is inherently a static material:

• It lacks environmental responsiveness

• It cannot distinguish between pathogenic and commensal microorganisms

• It does not allow spatiotemporal control

These limitations hinder its integration into advanced healthcare systems.

(5) System-Level Barriers

Beyond material properties, several practical factors impede implementation:

• High infrastructure replacement costs

• Difficulty in application to lightweight or flexible substrates

• Limited visibility of preventive effects

Transition to the Second Generation: Interface-Engineered, Non-Leaching Antimaterials

The limitations of copper alloys provide clear design principles for next-generation materials. In this context, AbedulAg⁺ represents both a conceptual and technological evolution.

Fundamental Shift:

• Copper: leaching-driven antimicrobial metal

• AbedulAg⁺: interface-confined, non-leaching ionic system

(1) From Leaching to Interfacial Immobilization

In AbedulAg⁺, Ag⁺ ions are immobilized within a ceramic matrix (e.g., TiO₂) through interfacial coordination. This enables:

• Long-term stability of antimicrobial activity

• Elimination of uncontrolled ion release

• Improved environmental and biological safety

This represents a fundamental transition from diffusion-based mechanisms to interfacial activity.

(2) Further Suppression of Evolutionary Resistance

While both copper and silver exhibit multi-target mechanisms, AbedulAg⁺ employs surface-confined, non-diffusive action, reducing selective pressure gradients in the environment. As a result, not only microbial survival but also evolutionary adaptation pathways may be suppressed.

(3) Interface Design and Functional Controllability

AbedulAg⁺ enables:

• Control of surface charge and coordination states

• Integration with photocatalytic and redox functionalities

• Application to flexible substrates such as textiles

This represents a shift from bulk materials to programmable antimicrobial interfaces.

(4) Compatibility with Modern Infection Control Systems

AbedulAg⁺ can be applied as a coating to existing materials, eliminating the need for infrastructure replacement. This directly addresses one of the major barriers that hindered copper adoption.

Conceptual Evolution: From Materials to Interfaces to Systems

The comparison between copper alloys and AbedulAg⁺ illustrates the following evolutionary stages:

• First Generation: Metallic Antimicrobial Materials
  Example: Copper alloys
  Mechanism: Ion release + contact killing
  Limitation: Lack of controllability and durability

• Second Generation: Nanoparticle-Based Systems
  Example: Nanosilver
  Mechanism: High reactivity and ion release
  Limitation: Toxicity and environmental impact

• Third Generation: Interface-Engineered Materials (This Study)
  Example: AbedulAg⁺
  Mechanism: Surface-confined ions
  Advantages: Durability, safety, controllability

Implications for Future Infection Control

Copper alloys demonstrated that continuous antimicrobial surfaces can reduce infection risk in clinical environments. However, their limitations indicate that the ultimate solution lies not in bulk materials, but in highly engineered interfacial systems.

Future research should focus on:

• Development of non-leaching antimicrobial interfaces

• Spatiotemporally controlled antimicrobial activity

• Integration with sensing technologies and AI

• Selective control that preserves commensal microbiota

Conclusion

Copper alloys established the feasibility of continuous antimicrobial materials and opened a new paradigm in infection control. However, their intrinsic limitations clearly point toward the necessity of transitioning to non-leaching, interface-engineered systems.

AbedulAg⁺ is not merely an improved material, but a platform technology for environmental infection control engineering, integrating durability, safety, and controllability. It represents a step toward a future in which infections are prevented not by treatment, but by design.

​

​